Interferon alfa-n1 (Wellferon)® in juvenile onset recurrent respiratory papillomatosis: Results of a randomized study in twelve collaborative institutions

Laryngoscope

Volumn 98, Issue 3, 1988, Pages 334-340

  Leventhal, B ^a   Dedo, H ^d   Gardiner, L ^g   McCabe, B F ^h   Richardson, M ^j   Whisnant, J ^l   Kashima, H ^a   Clark, K ^b   Donovan, D ^e   Goepfert, H ^e   Mounts, P ^a   Singleton, G ^k   Wold, D ^l   Cohen, S ^c   Fearon, B ^f   Lusk, R ^h   Muntz, H ⁱ   Weck, P ^l   Yonkers, A ^m  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

^f HOSPITAL FOR SICK CHILDREN   (Canada)

^g YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

ⁱ ST LOUIS CHILDREN S HOSPITAL   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^l Burroughs Wellcome Co   (United States)

^m UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN1 INTERFERON; INTERFERON; LIVER ENZYME;

BLOOD TOXICITY; CHILL; CLINICAL TRIAL; CONTROLLED STUDY; FATIGUE; FEVER; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LASER COAGULATION; MAJOR CLINICAL STUDY; METHODOLOGY; PAPILLOMATOSIS; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; COMBINED MODALITY THERAPY; COMPARATIVE STUDY; FEMALE; HUMAN; INTERFERON TYPE I; LASER SURGERY; MALE; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA; RANDOM ALLOCATION; RECOMBINANT PROTEINS; RESPIRATORY TRACT NEOPLASMS;

EID: 0023911486     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mounts, P. and Shah, K. V.: Respiratory Papillomatosis: Etiological Relation to Genital Tract Papillomaviruses. Prog. Med. Virol., 29:90,1984.
2. Haglund, S., Lundquist, P., Cantell, K., et al.: Interferon Therapy in Juvenile Laryngeal Papillomatosis. Arch. Otolaryngol., 107:327,1981.
3. Goepfert, H., Sessions, R. B., Gutterman, J. U., et al.: Leukocyte Interferon in Patients with Juvenile Laryngeal Papillomatosis. Ann. Otol. Rhinol. Laryngol., 91:431,1982.
4. Sessions, R. B., Goepfert, H., Donovan, D. T., et al.: Further Observations on the Treatment of Recurrent Respiratory Papillomatosis with Interferon: A Comparison of Sources. Ann. Otol. Rhinol. Laryngol., 92:456-461,1983.
5. Lundquist, P. G., Haglund, S., Carlsoo, B., et al.: Interferon Therapy in Juvenile Laryngeal Papillomatosis. Otolaryngol. Head Neck Surg., 92(4):386-391,1984.
6. Bomholt, A.: Interferon Therapy for Laryngeal Papillomatosis in Adults. Arch. Otolaryngol., 109:550,1983.
7. McCabe, B. F. and Clark, K. E.: Interferon and Laryngeal Papillomatosis: The Iowa Experience. Ann. Otol. Rhinol. Laryngol., 92:2,1983.
8. Sessions, R. B., Dichtel, W. S. and Goepfert, H.: Treatment of Recurrent Respiratory Papillomatosis with Interferon. Ear Nose Throat J., 63:488-493,1984.
9. Zenner, H. P., Kley, W., Claros, P., et al.: Recombinant Interferon-Apha-2C in Laryngeal Papillomatosis: Preliminary Results of a Prospective Multicentre Trial. Oncology, 42:15-28, 1985.
10. Schouten, T. J., Weimar, W., Bos, J. H., et al.:. Treatment of Juvenile Laryngeal Papillomatosis with Two Types of Interferon. Laryngoscope, 92:686-688,1982.
11. Whisnant, J. K., Kashima, H., Leventhal, B., et al.:. Interferon Treatment of Juvenile Laryngeal Papillomatosis: The Design of a Cooperative Trial with Wellferon. Elsevier Scientific Publishers, Amsterdam, Netherlands, pp. 601-609, 1985.
12. Finter, N. B. and Fantes, K. H.: The Purity and Safety of Interferon Prepared for Clinical Use: The Case of Lymphoblas-toid Interferon. In: Interferon (Vol. II). Gresser (Ed.). Academic Press, Inc., London, pp. 65-80, 1980.
13. Mounts, P. and Kashima, H. K.: Association of Human Papillomavirus Subtype and Clinical Course in Respiratory Papillomatosis. Laryngoscope, 94:28-33,1984.
14. Kashima, H., et al.: Scoring System to Assess Severity and Course in Recurrent Respiratory Papillomatosis. In: Papillomaviruses: Molecular and Clinical Aspects. Aan R. Liss, Inc., New York, pp. 125-135, 1985.
15. Strander, H. A.: Interferon in the Treatment of Human Papilloma Virus. Med. Clin. North Am. (Suppl.) (May), pp. 19-23, 1986.